NP

Nayanaben Parshottambhai Ramotia

Active Director Director DIN 00775760
DIN 00775760 First appointment Apr 1999 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Apr 1999
Shareholding value •••• Premium profile

About Nayanaben Parshottambhai Ramotia

Data last updated:

Nayanaben Parshottambhai Ramotia has 27 years in corporate governance. Holds Director role. Currently with 3 companies, including Panzer Pharmaceutical Private Limited and Yew Pharma Private Limited. Formerly with 2 companies, such as Abnx Biochem Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹7.21 Cr; the largest is Yew Pharma Private Limited at ₹3.84 Cr (FY 2025).

DIN 00775760
Primary Designation Director
First Appointment 26 Apr 1999
Oldest Company Age 29 yrs
Largest company Yew Pharma Private Limited · ₹3.84 Cr (FY 2025)
Combined revenue ₹7.21 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Yew Pharma Private Limited U24231GJ1999PTC035849
Director26 Apr 19991999₹3.84 Cr (FY 2025)Active
Director13 Jul 20101997₹2.13 Cr (FY 2025)Active
Onus Pharmaceutical Private Limited U24232GJ2007PTC050805
Director11 May 20072007₹1.25 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Abnx Biochem Private Limited U24100GJ2021PTC127392
Director18 Nov 20212021–Active
Parli Cosmetic Laser Private Limited U85110GJ2008PTC054767
Director13 Aug 20082008–Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Panzer Pharmaceutical Private Limited
Yew Pharma Private Limited
Onus Pharmaceutical Private Limited
Parli Cosmetic Laser Private Limited
Premium access

Shareholding and investment profile for Nayanaben Parshottambhai Ramotia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nayanaben Parshottambhai Ramotia

Nayanaben Parshottambhai Ramotia has 27 years in corporate governance. Holds Director role. Currently with 3 companies, including Panzer Pharmaceutical Private Limited and Yew Pharma Private Limited. Formerly with 2 companies, such as Abnx Biochem Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹7.21 Cr; the largest is Yew Pharma Private Limited at ₹3.84 Cr (FY 2025).

Nayanaben Parshottambhai Ramotia is associated with 3 companies as Director, including Yew Pharma Private Limited (₹3.84 Cr), Panzer Pharmaceutical Private Limited (₹2.13 Cr), Onus Pharmaceutical Private Limited (₹1.25 Cr).

Nayanaben Parshottambhai Ramotia has expertise in General Business.

Nayanaben Parshottambhai Ramotia has 27 years in corporate governance.

By reported revenue, the largest current company of Nayanaben Parshottambhai Ramotia is Yew Pharma Private Limited, with revenue of ₹3.84 Cr (FY 2025).

The 3 current companies of Nayanaben Parshottambhai Ramotia that report revenue have a combined latest revenue of ₹7.21 Cr.

Nayanaben Parshottambhai Ramotia currently holds positions at 3 companies: Yew Pharma Private Limited (₹3.84 Cr), Panzer Pharmaceutical Private Limited (₹2.13 Cr), Onus Pharmaceutical Private Limited (₹1.25 Cr).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available